|
NL181407B
(nl)
|
1952-09-20 |
|
Merck & Co Inc |
Verbetering van een werkwijze ter bereiding van een farmaceutisch preparaat met antibacteriele werking, dat een combinatie van een verbinding van het 3-fluor-d-alaninetype en een cycloserineverbinding bevat.
|
|
JP2000319257A
(ja)
|
1969-01-06 |
2000-11-21 |
Eisai Co Ltd |
１−ベンジル−４−［（５，６−ジメトキシ−２−フルオロ−１−インダノン）−２−イル］メチルピペリジン
|
|
IT1045043B
(it)
|
1975-08-13 |
1980-04-21 |
Isf Spa |
Derivati pirrolidinici
|
|
IT1075280B
(it)
|
1977-02-11 |
1985-04-22 |
Isf Spa |
Procedimento per la preparazione di derivati pirrolidinici
|
|
BE864269A
(fr)
|
1977-03-03 |
1978-06-16 |
Parke Davis & Co |
Nouveaux n-(aminoalkyl substitue)-2-oxo-1-pyrrolidine-acetamides et procedes pour les produire
|
|
ATE27T1
(de)
|
1978-05-08 |
1981-04-15 |
Ucb Sa |
Lactam-n-essigsaeuren und ihre amide, verfahren zu ihrer herstellung und heilmittel, die sie enthalten
|
|
US4654370A
(en)
|
1979-03-12 |
1987-03-31 |
Abbott Laboratories |
Glyceryl valproates
|
|
US4372960A
(en)
|
1980-12-12 |
1983-02-08 |
Warner-Lambert Company |
Quaternary derivatives of N-(substituted-aminoalkyl)-2-oxo-1-pyrrolidine-acetamides as cognition activators
|
|
FR2515179A1
(fr)
|
1981-07-24 |
1983-04-29 |
Hoffmann La Roche |
Derives de pyrrolidine, leur procede de preparation, les intermediaires pour leur synthese et leur application therapeutique
|
|
IL67623A
(en)
|
1983-01-05 |
1984-09-30 |
Teva Pharma |
1'-ethoxycarbonyloxyethyl ester of valproic acid,its preparation and pharmaceutical compositions containing it
|
|
IL72381A
(en)
|
1983-07-20 |
1988-03-31 |
Sanofi Sa |
Pharmaceutical composition based on valproic acid
|
|
US4558070A
(en)
|
1983-10-26 |
1985-12-10 |
Abbott Laboratories |
Acid salts of valproic acid
|
|
GB8412357D0
(en)
|
1984-05-15 |
1984-06-20 |
Ucb Sa |
Pharmaceutical composition
|
|
GB8412358D0
(en)
|
1984-05-15 |
1984-06-20 |
Ucb Sa |
Pharmaceutical composition
|
|
US4668687A
(en)
|
1984-07-23 |
1987-05-26 |
Bristol-Myers Company |
Psychogeriatric 1-(2-pyrimidinyl)piperazinyl derivatives of 1-pyrrolidin-2-ones
|
|
US4913906B1
(en)
|
1985-02-28 |
2000-06-06 |
Yissum Res Dev Co |
Controlled release dosage form of valproic acid
|
|
IL74497A
(en)
|
1985-03-05 |
1990-02-09 |
Proterra Ag |
Pharmaceutical compositions containing phenyl carbamate derivatives and certain phenyl carbamate derivatives
|
|
JPS6222785A
(ja)
|
1985-07-23 |
1987-01-30 |
Sanwa Kagaku Kenkyusho:Kk |
新規な２−オキソピロリジン化合物及びその塩、その製法並びにこれらを有効成分とする脳機能障害の予防及び治療剤
|
|
US4663318A
(en)
|
1986-01-15 |
1987-05-05 |
Bonnie Davis |
Method of treating Alzheimer's disease
|
|
IT1190133B
(it)
|
1986-06-19 |
1988-02-10 |
Chiesi Farma Spa |
Derivati di acido valproico e di acido (e)-2-valproenoico,procedimento per la loro preparazione e relative composizioni farmaceutiche
|
|
US4816456A
(en)
|
1986-10-01 |
1989-03-28 |
Summers William K |
Administration of monoamine acridines in cholinergic neuronal deficit states
|
|
HU201906B
(en)
|
1987-03-04 |
1991-01-28 |
Sandoz Ag |
Process for producing phenyl-carbamate derivative and acid additional salts and pharmaceutical compositions containing them
|
|
EP0282959A3
(en)
|
1987-03-17 |
1989-05-31 |
Hoechst-Roussel Pharmaceuticals Incorporated |
Substituted 9-amino-tetrahydro-acridines and related compounds, a process for their preparation and their use as medicaments
|
|
DE3709230A1
(de)
|
1987-03-20 |
1988-10-06 |
Desitin Arzneimittel Gmbh |
Neues calciumsalz der valproinsaeure
|
|
IT1225462B
(it)
|
1987-04-03 |
1990-11-14 |
Mediolanum Farmaceutici Srl |
Sali organici di derivati della fisostigmina
|
|
US5002955A
(en)
|
1987-04-23 |
1991-03-26 |
Hoechst-Roussel Pharmaceuticals Inc. |
Fused heteroalkylene quinolinamines and use as cholinergic agents
|
|
JP2755403B2
(ja)
|
1987-05-04 |
1998-05-20 |
デイービス、ボニー |
アルツハイマー病の治療のための化合物
|
|
US5187165A
(en)
|
1987-05-15 |
1993-02-16 |
Hoechst-Roussel Pharmaceuticals Inc. |
Memory enhancing and analgesic 1,2,3a,8,8a-hexahydro-3a,8(and 1,3a,8)-di(and tri)methylpyrrolo[2,3-b]indoles
|
|
FI95572C
(fi)
|
1987-06-22 |
1996-02-26 |
Eisai Co Ltd |
Menetelmä lääkeaineena käyttökelpoisen piperidiinijohdannaisten tai sen farmaseuttisen suolan valmistamiseksi
|
|
JPS6422883A
(en)
|
1987-07-17 |
1989-01-25 |
Sanwa Kagaku Kenkyusho Co |
1-pyrrolidine acetamide derivative, its salt, production thereof and prophylactic and remedial agent for cereral dysfunction containing said derivative and salt as active ingredient
|
|
EP0300111B1
(en)
|
1987-07-22 |
1991-10-16 |
Farvalsa AG |
A moisture stable solid valproic acid formulation and a method of preparing the same
|
|
US4950658A
(en)
|
1988-12-06 |
1990-08-21 |
Board Of Trustees Of Southern Illinois Univ. |
Method of medical treatment of Alzheimer's disease
|
|
HUT53607A
(en)
|
1989-01-17 |
1990-11-28 |
Hoffmann La Roche |
Process for production of derivatives of cyclohexan-acetamid
|
|
FR2643556B1
(fr)
|
1989-02-27 |
1993-03-05 |
Sanofi Sa |
Composition pharmaceutique a liberation prolongee d'acide valproique
|
|
US4981870A
(en)
|
1989-03-07 |
1991-01-01 |
Pfizer Inc. |
Use of 4-phenyl-1,2,3,4-tetrahydro-1-naphthalenamine derivatives in the treatment of psychosis, inflammation and as immunosuppressants
|
|
US5238945A
(en)
|
1989-04-11 |
1993-08-24 |
H. Lundbeck A/S |
Method of treating psychoses
|
|
US5364866A
(en)
|
1989-05-19 |
1994-11-15 |
Hoechst-Roussel Pharmaceuticals, Inc. |
Heteroarylpiperidines, pyrrolidines and piperazines and their use as antipsychotics and analetics
|
|
EP0403713A1
(en)
|
1989-06-22 |
1990-12-27 |
Merrell Dow Pharmaceuticals Inc. |
Novel acetylcholinesterase inhibitors
|
|
US5693668A
(en)
|
1989-06-22 |
1997-12-02 |
Merrell Pharmaceuticals Inc. |
Acetylcholinesterase inhibitors
|
|
IT1231477B
(it)
|
1989-07-12 |
1991-12-07 |
Sigma Tau Ind Farmaceuti |
(pirrolidin-2-one-1-il) acetammidi quali attivatori dei processi di apprendimento e della memoria e composizioni farmaceutiche comprendenti tali composti
|
|
US4999430A
(en)
|
1989-07-31 |
1991-03-12 |
Warner-Lambert Company |
Derivatives of 1,2,3,4-tetrahydro-9-acrisinamine
|
|
DE3927049A1
(de)
|
1989-08-16 |
1991-02-21 |
Sandoz Ag |
Halogenalkyl-phenyl-ketone und deren hydrate, ihre herstellung und verwendung
|
|
WO1991003467A1
(en)
|
1989-08-30 |
1991-03-21 |
Pfizer Inc. |
Benzazabicyclic carbamates as novel cholinesterase inhibitors
|
|
US4914102A
(en)
|
1989-09-28 |
1990-04-03 |
Hoechst Roussel Pharmaceuticals, Inc. |
N-aminocarbamates related to physostigmine, pharmacentical compositions and use
|
|
NZ237241A
(en)
|
1990-03-02 |
1993-11-25 |
Pharmetrix Corp |
Method for increasing the storage stability of physostigmine
|
|
JP2807577B2
(ja)
|
1990-06-15 |
1998-10-08 |
エーザイ株式会社 |
環状アミド誘導体
|
|
US5102891A
(en)
|
1990-07-23 |
1992-04-07 |
Hoechst-Roussel Pharmaceuticals Inc. |
1-(substituted pyridinylamino)-1H-indol-5-yl substituted carbamates
|
|
US5264442A
(en)
|
1990-08-13 |
1993-11-23 |
Hoechst-Roussel Pharmaceuticals Incorporated |
Carbamoyl-1-(pyridinylalkyl)-1H-indoles, indolines and related analogs
|
|
TW200462B
(enExample)
|
1990-09-27 |
1993-02-21 |
Hoechst Roussel Pharma |
|
|
US5190951A
(en)
|
1990-10-19 |
1993-03-02 |
Ss Pharmaceutical Co., Ltd. |
Quinoline derivatives
|
|
JP2965675B2
(ja)
|
1990-11-21 |
1999-10-18 |
エーザイ株式会社 |
（―）―１―ベンジル―４―〔（５，６―ジメトキシ―１―インダノン）―２―イル〕メチルピペリジンの製造方法
|
|
TW197435B
(enExample)
|
1990-11-22 |
1993-01-01 |
Takeda Pharm Industry Co Ltd |
|
|
US5668117A
(en)
|
1991-02-22 |
1997-09-16 |
Shapiro; Howard K. |
Methods of treating neurological diseases and etiologically related symptomology using carbonyl trapping agents in combination with previously known medicaments
|
|
US5750542A
(en)
|
1993-09-28 |
1998-05-12 |
Pfizer |
Benzisoxazole and benzisothizole derivatives as cholinesterase inhibitors
|
|
RU2119920C1
(ru)
|
1991-03-28 |
1998-10-10 |
Эйсай Ко., Лтд. |
Гетероцикло-циклические производные аминов или их фармацевтически приемлемые соли, промежуточные соединения, фармацевтическая композиция, способ ингибирования холинэстеразы, способ получения соединений
|
|
US5104880A
(en)
|
1991-05-01 |
1992-04-14 |
Mayo Foundation For Medical Education And Research |
Huperzine a analogs as acetylcholinesterase inhibitors
|
|
CA2067614C
(en)
|
1991-05-02 |
2002-07-30 |
Eiichi Otomo |
Agent for improving dementia
|
|
FR2677019B1
(fr)
|
1991-05-27 |
1994-11-25 |
Pf Medicament |
Nouvelles piperidines disubstituees-1,4, leur preparation et leur application en therapeutique.
|
|
US5106856A
(en)
|
1991-06-07 |
1992-04-21 |
Hoechst-Roussel Pharmaceuticals Inc. |
[(Arylalkylpiperidin-4-yl)methyl]-2a,3,4,5-tetrahydro-1(2H)-acenaphthylen-1-ones and related compounds
|
|
FR2679555B1
(fr)
|
1991-07-25 |
1993-11-19 |
Fabre Medicament Pierre |
Nouveaux derives de l'uree, leur preparation et leur application en therapeutique.
|
|
AU665207B2
(en)
|
1991-07-29 |
1995-12-21 |
Warner-Lambert Company |
Quinazoline derivatives as acetylcholinesterase inhibitors
|
|
IT1251166B
(it)
|
1991-08-09 |
1995-05-04 |
Chiesi Farma Spa |
Derivati di geneserina,loro preparazione e composizioni farmaceutiche che li contengono
|
|
US5246947A
(en)
|
1991-09-23 |
1993-09-21 |
Hoechst-Roussel Pharmaceuticals Incorporated |
Substituted pyridinylamino-1,2-benzisothiazoles and their use for treating depression
|
|
US5231093A
(en)
|
1991-10-01 |
1993-07-27 |
Hoechst-Roussel Pharmaceuticals Incorporated |
Carbamate derivatives of 4-amino-3-isoxazolidinones, 3-amino-1-hydroxypyrrolidin-2-ones and 1-amino-1-cyclopropanecarboxylic acid analogs
|
|
TW263504B
(enExample)
|
1991-10-03 |
1995-11-21 |
Pfizer |
|
|
ES2042384B1
(es)
|
1991-12-26 |
1994-06-01 |
Boehringer Ingelheim Espana |
Procedimiento para obtener derivados bis-piridinicos.
|
|
AU3171493A
(en)
|
1991-12-31 |
1993-07-28 |
Fujisawa Pharmaceutical Co., Ltd. |
Oxadiazole derivatives having acetylcholinesterase-inhibitory and muscarinic agonist activity
|
|
AU4275793A
(en)
|
1992-02-25 |
1993-09-13 |
Warner-Lambert Company |
Cytoprotective compositions containing pyruvate and antioxidants
|
|
US5439930A
(en)
|
1992-04-14 |
1995-08-08 |
Russian-American Institute For New Drug Development |
Biologically active n-acylprolydipeptides having antiamnestic, antihypoxic and anorexigenic effects
|
|
IT1254996B
(it)
|
1992-06-25 |
1995-10-11 |
Mediolanum Farmaceutici Srl |
Esteri amminoalchilcarbammici dell'eserolina atti all'impiego come anticolinesterasici e relativo procedimento di preparazione
|
|
US5440023A
(en)
|
1992-09-18 |
1995-08-08 |
Beckman Instruments, Inc. |
Method for making valproic acid derivatives
|
|
TW251284B
(enExample)
|
1992-11-02 |
1995-07-11 |
Pfizer |
|
|
EP0611769A1
(en)
|
1993-02-16 |
1994-08-24 |
Merrell Dow Pharmaceuticals Inc. |
Silylated acetylcholinesterase inhibitors
|
|
AU4982293A
(en)
|
1993-03-02 |
1994-09-26 |
Fujisawa Pharmaceutical Co., Ltd. |
Novel heterocyclic compound
|
|
EP0627400A1
(en)
|
1993-06-04 |
1994-12-07 |
Merrell Dow Pharmaceuticals Inc. |
Aromatic acetylcholinesterase inhibitors
|
|
SE9302080D0
(sv)
|
1993-06-16 |
1993-06-16 |
Ab Astra |
New compounds
|
|
GB9319732D0
(en)
|
1993-09-24 |
1993-11-10 |
Ucb Sa |
Use of (s)-alpha-ethyl-2-oxo-l-pyrrolidineacetamide for the treatment of anxiety
|
|
US5744476A
(en)
|
1994-06-27 |
1998-04-28 |
Interneuron Pharmaceuticals, Inc. |
Dopamine D1 agonists for the treatment of dementia
|
|
IL118279A
(en)
|
1995-06-07 |
2006-10-05 |
Abbott Lab |
Compounds 3 - Pyridyloxy (or Thio) Alkyl Heterocyclic Pharmaceutical Compositions Containing Them and Their Uses for Preparing Drugs to Control Synaptic Chemical Transmission
|
|
IL115113A
(en)
|
1995-08-31 |
2002-11-10 |
Israel State |
3-carbamoyloxy pyridinium derivatives and pharmaceutical compositions containing them
|
|
ES2100129B1
(es)
|
1995-10-11 |
1998-02-16 |
Medichem Sa |
Nuevos compuestos aminopiridinicos policiclicos inhibidores de acetilcolinesterasa, procedimiento para su preparacion y su utilizacion.
|
|
WO1997019059A1
(en)
|
1995-11-17 |
1997-05-29 |
Sibia Neurosciences, Inc. |
Novel substituted aryl compounds useful as modulators of acetylcholine receptors
|
|
US5783584A
(en)
|
1995-12-11 |
1998-07-21 |
Mayo Foundation For Medical Education And Research |
THA analogs useful as cholinesterase inhibitors
|
|
GB9606736D0
(en)
|
1996-02-19 |
1996-06-05 |
Shire International Licensing |
Therapeutic method
|
|
DK0892796T3
(da)
|
1996-04-12 |
2001-11-19 |
Aventis Pharma Inc |
Isatinderivater som acetylcholinesteraseinhibitorer og analgetika
|
|
AU1153097A
(en)
|
1996-06-07 |
1998-01-05 |
Eisai Co. Ltd. |
Stable polymorphs of donepezil (1-benzyl-4-{(5,6-dimethoxy-1-indanon)-2-yl}methylpiperidine ) hydrochloride and process for production
|
|
TW513409B
(en)
|
1996-06-07 |
2002-12-11 |
Eisai Co Ltd |
Polymorphs of donepezil hydrochloride
|
|
CA2180703A1
(en)
|
1996-07-08 |
1998-01-09 |
Paul Marie Victor Gilis |
Fast-dissolving galanthamine hydrobromide tablet
|
|
EA006626B1
(ru)
|
1996-07-24 |
2006-02-24 |
Дюпон Фармасьютикалз Компани |
Азолопиримидины, фармацевтическая композиция и способ лечения
|
|
US5965571A
(en)
|
1996-08-22 |
1999-10-12 |
New York University |
Cholinesterase inhibitors for treatment of Parkinson's disease
|
|
IT1285801B1
(it)
|
1996-10-10 |
1998-06-24 |
Sigma Tau Ind Farmaceuti |
Procedimento migliorato per la preparazione dell'acido valproico
|
|
AU5716898A
(en)
|
1997-01-08 |
1998-08-03 |
Warner-Lambert Company |
Acetylcholinesterase inhibitors in combination with muscarinic agonists for the treatment of alzheimer's disease
|
|
PT971713E
(pt)
|
1997-03-03 |
2003-09-30 |
Eisai Co Ltd |
Utilizacao de inibidores da colinesterase para tratamento de desordens da atencao
|
|
GB9716879D0
(en)
|
1997-08-08 |
1997-10-15 |
Shire Int Licensing Bv |
Treatment of attention deficit disorders
|
|
AU8742198A
(en)
|
1997-08-15 |
1999-03-08 |
Shire International Licensing B.V. |
Use of cholinesterase inhibitor for treating diseases associated with pro teolytic enzyme activity
|
|
US6479523B1
(en)
|
1997-08-26 |
2002-11-12 |
Emory University |
Pharmacologic drug combination in vagal-induced asystole
|
|
UA72189C2
(uk)
|
1997-11-17 |
2005-02-15 |
Янссен Фармацевтика Н.В. |
Фармацевтична композиція, що містить водну суспензію субмікронних ефірів 9-гідроксирисперидон жирних кислот
|
|
US6245911B1
(en)
|
1997-12-05 |
2001-06-12 |
Eisai Co., Ltd. |
Donepezil polycrystals and process for producing the same
|
|
US6131106A
(en)
|
1998-01-30 |
2000-10-10 |
Sun Microsystems Inc |
System and method for floating-point computation for numbers in delimited floating point representation
|
|
GB9805561D0
(en)
|
1998-03-16 |
1998-05-13 |
Merck Sharp & Dohme |
A combination of therapeutic agents
|
|
US6262081B1
(en)
|
1998-07-10 |
2001-07-17 |
Dupont Pharmaceuticals Company |
Composition for and method of treating neurological disorders
|
|
US6218383B1
(en)
|
1998-08-07 |
2001-04-17 |
Targacept, Inc. |
Pharmaceutical compositions for the prevention and treatment of central nervous system disorders
|
|
IL125809A
(en)
|
1998-08-17 |
2005-08-31 |
Finetech Lab Ltd |
Process and intermediates for production of donepezil and related compounds
|
|
IT1304904B1
(it)
|
1998-09-11 |
2001-04-05 |
Eisai Co Ltd |
Derivati anticolinesterasici per il trattamento delle sindromidolorose funzionali e/o organiche
|
|
HK1039745A1
(zh)
|
1998-10-16 |
2002-05-10 |
Janssen Pharmaceutica N.V. |
用於改善识别的非典型抗精神病药和乙酰胆碱酯酶
|
|
EP1133230A4
(en)
|
1998-11-23 |
2004-05-26 |
Bonnie M Davis |
DOSAGE FORMULAS FOR ACETYLCHOLINESTERASE INHIBITORS
|
|
ATE306264T1
(de)
|
1998-12-11 |
2005-10-15 |
Bonnie M Davis |
Verwendung von acetylcholinesterase inhibitoren zur modulierung der hypothalamus-hypophysen- gonadenachse
|
|
US6277866B1
(en)
|
1999-03-03 |
2001-08-21 |
Eisai Co., Ltd. |
1-benzyl-4[(5,6-dimethoxy-2-fluoro-1-indanon)-2-yl]methylpiperidine
|
|
EP1086706B1
(en)
|
1999-03-31 |
2003-11-26 |
Eisai Co., Ltd. |
Stabilized compositions containing nootropic drugs
|
|
EP1050303A3
(en)
|
1999-04-27 |
2003-01-15 |
Pfizer Products Inc. |
Methods and compositions for treating age-related behavioral disorders in companion animals
|
|
WO2001000215A1
(en)
|
1999-06-25 |
2001-01-04 |
Wake Forest University |
Compositions for treating or preventing neurodegeneration and cognitive decline
|
|
JP4242048B2
(ja)
|
1999-09-01 |
2009-03-18 |
エーザイ・アール・アンド・ディー・マネジメント株式会社 |
４−置換ピペリジン誘導体
|
|
ATE360612T1
(de)
|
1999-09-01 |
2007-05-15 |
Eisai R&D Man Co Ltd |
In 4-stellung substituierte piperidinderivate
|
|
AU5786300A
(en)
|
1999-09-22 |
2001-04-24 |
Schering Corporation |
Muscarinic antagonists
|
|
US6620802B1
(en)
|
1999-11-23 |
2003-09-16 |
Corcept Therapeutics, Inc. |
Methods of treating mild cognitive impairment using a glucocorticoid-specific receptor antagonist
|
|
YU37602A
(sh)
|
1999-12-01 |
2005-07-19 |
Ucb S.A. |
Derivat pirolidinacetamida sam ili u kombinaciji za tretman poremećaja cns
|
|
DK1311272T3
(da)
|
2000-03-03 |
2007-02-26 |
Eisai R&D Man Co Ltd |
Hidtil ukendte fremgangsmåder hvor der anvendes cholinesteraseinhibitorer
|
|
US20030144255A1
(en)
|
2000-03-06 |
2003-07-31 |
Bain Allen I |
Compositions for prevention and treatment of dementia
|
|
JP4150519B2
(ja)
|
2000-04-13 |
2008-09-17 |
エーザイ・アール・アンド・ディー・マネジメント株式会社 |
１−ベンジルピリジニウム塩を含有してなるアセチルコリンエステラーゼ阻害剤
|
|
US20010036949A1
(en)
|
2000-05-09 |
2001-11-01 |
Coe Jotham Wadsworth |
Pharmaceutical composition and method of treatment of diseases of cognitive dysfunction in a mammal
|
|
US6756385B2
(en)
|
2000-07-31 |
2004-06-29 |
Pfizer Inc. |
Imidazole derivatives
|
|
US20020151591A1
(en)
|
2000-10-17 |
2002-10-17 |
Anabella Villalobos |
Combination use of acetylcholinesterase inhibitors and GABAa inverse agonists for the treatment of cognitive disorders
|
|
JPWO2002053153A1
(ja)
|
2000-12-28 |
2004-04-30 |
第一製薬株式会社 |
神経因性疼痛治療及び予防薬
|
|
US6610326B2
(en)
|
2001-02-16 |
2003-08-26 |
Andrx Corporation |
Divalproex sodium tablets
|
|
WO2002067931A1
(en)
|
2001-02-23 |
2002-09-06 |
Johns Hopkins University |
Treatment of tics, tremors and related disorders
|
|
CA2442717A1
(en)
|
2001-03-15 |
2002-09-26 |
Saegis Pharmaceuticals, Inc. |
Methods for restoring cognitive function following systemic stress
|
|
ATE315555T1
(de)
|
2001-05-11 |
2006-02-15 |
Pfizer Prod Inc |
Thiazolderivate und ihre verwendung als cdk- inhibitoren
|
|
US8354438B2
(en)
|
2001-08-08 |
2013-01-15 |
Michael Chez |
Neurological functions
|
|
CA2457982C
(en)
|
2001-08-22 |
2009-11-03 |
Daiichi Pharmaceutical Co., Ltd. |
Use of nefiracetam for treating neurodegeneration
|
|
US20030060423A1
(en)
|
2001-08-30 |
2003-03-27 |
Plata-Salaman Carlos R. |
Co-therapy for the treatment of dementia and associated behavioral manifestations comprising anticonvulsant derivatives and acetylcholinesterase inhibitors
|
|
US7235579B2
(en)
|
2001-10-16 |
2007-06-26 |
Memory Pharmaceuticals Corp. |
Phosphodiesterase 4 inhibitors
|
|
US6495700B1
(en)
|
2002-01-09 |
2002-12-17 |
Axonyx, Inc. |
Process for producing phenserine and its analog
|
|
US6759552B2
(en)
|
2002-03-28 |
2004-07-06 |
Council Of Scientific And Industrial Research |
Compound as cholinesterase inhibitor and its isolation from fungus sporotrichum species
|
|
DE60318306T2
(de)
|
2002-03-29 |
2008-12-11 |
Eisai R&D Management Co., Ltd. |
(1-indanon)-(1,2,3,6-tetrahydropyridin)derivat
|
|
DE60324544D1
(de)
|
2002-04-26 |
2008-12-18 |
Schering Corp |
Muskarin antagonisten
|
|
WO2004034963A2
(en)
|
2002-05-17 |
2004-04-29 |
Eisai Co., Ltd. |
Methods and compositions using cholinesterase inhibitors
|
|
DE60324788D1
(de)
|
2002-05-31 |
2009-01-02 |
Lundbeck & Co As H |
Kombination aus einem nmda-antagonist und acetylcholinesterase-hemmern zur behandlung der alzheimer-krankheit
|
|
US20040116506A1
(en)
|
2002-06-20 |
2004-06-17 |
Krusz John Claude |
Use of levetiracetam for treating or preventing acute headaches
|
|
US7557137B2
(en)
|
2002-08-05 |
2009-07-07 |
Bristol-Myers Squibb Company |
Gamma-lactams as beta-secretase inhibitors
|
|
US7635709B2
(en)
|
2002-09-26 |
2009-12-22 |
The United States Of America As Represented By The Department Of Veterans Affairs |
Compositions and methods for bowel care in individuals with chronic intestinal pseudo-obstruction
|
|
GB0223494D0
(en)
|
2002-10-09 |
2002-11-13 |
Neuropharma Sa |
Dual binding site acetylcholinesterase inhibitors for the treatment of alzheimer's disease
|
|
CN100339070C
(zh)
|
2002-10-24 |
2007-09-26 |
莫茨药物股份两合公司 |
包含1－氨基环己烷衍生物类和乙酰胆碱酯酶抑制剂类的药物组合物
|
|
US20040191803A1
(en)
|
2002-11-22 |
2004-09-30 |
Michela Gallagher |
Target for therapy of cognitive impairment
|
|
EP1625378A4
(en)
|
2002-12-03 |
2007-05-16 |
Ucb Sa |
METHOD OF IDENTIFYING AGENTS FOR THE TREATMENT OF CEREALS, NEUROLOGICAL DISEASES, ENDOCRINOPATHIES AND HORMONE DISEASES
|
|
US7090985B2
(en)
|
2002-12-03 |
2006-08-15 |
Ucb, S.A. |
Methods for the identification of agents for the treatment of seizures, neurological diseases, endocrinopathies and hormonal diseases
|
|
JP2006510662A
(ja)
|
2002-12-11 |
2006-03-30 |
ファルマシア・アンド・アップジョン・カンパニー・エルエルシー |
α７ニコチン性アセチルコリン受容体アゴニストとその他の化合物との組合せによる疾患の治療
|
|
KR100831545B1
(ko)
|
2003-03-06 |
2008-05-21 |
셀진 코포레이션 |
중추 신경계 장애의 치료 또는 관리를 위한 선택적사이토카인 억제 약물의 사용 방법 및 그를 포함하는조성물
|
|
ITMI20030573A1
(it)
|
2003-03-24 |
2004-09-25 |
Nikem Research Srl |
Composti ad azione nootropica, loro preparazione,
|
|
US20040191334A1
(en)
|
2003-03-24 |
2004-09-30 |
Pang-Chui Shaw |
Use of transhinone derivates as cholinesterase inhibitors in treating related diseases
|
|
US7732162B2
(en)
|
2003-05-05 |
2010-06-08 |
Probiodrug Ag |
Inhibitors of glutaminyl cyclase for treating neurodegenerative diseases
|
|
CN102166359A
(zh)
|
2003-05-23 |
2011-08-31 |
大塚制药株式会社 |
用于治疗情感障碍的喹诺酮衍生物和情绪稳定剂
|
|
GB0322140D0
(en)
|
2003-09-22 |
2003-10-22 |
Pfizer Ltd |
Combinations
|
|
US7244843B2
(en)
|
2003-10-07 |
2007-07-17 |
Bristol-Myers Squibb Company |
Modulators of serotonin receptors
|
|
WO2005035523A1
(en)
|
2003-10-08 |
2005-04-21 |
Pfizer Japan Inc. |
Fused lactam compounds
|
|
ATE519486T1
(de)
|
2003-10-16 |
2011-08-15 |
Neurosearch As |
Pharmazeutische zusammensetzung mit einem monoamin-neurotransmitter-wiederaufnahmehemmer und einem acetylcholinesterase-hemmer
|
|
US7897639B2
(en)
|
2003-10-21 |
2011-03-01 |
Colucid Pharmaceuticals, Inc. |
Carbamoyl esters that inhibit cholinesterase and release pharmacologically active agents
|
|
WO2005072713A2
(en)
|
2004-01-27 |
2005-08-11 |
The Feinstein Institute For Medical Research |
Cholinesterase inhibitors for treating inflammation
|
|
WO2005074535A2
(en)
|
2004-01-30 |
2005-08-18 |
Eisai Co., Ltd. |
Cholinesterase inhibitors for spinal cord disorders
|
|
AU2005215767A1
(en)
|
2004-02-13 |
2005-09-01 |
Adamas Pharmaceuticals, Inc. |
Combination of an NMDA receptor antagonist and an anti-epileptic drug for the treatment of epilepsy and other CNS disorders
|
|
US20050182044A1
(en)
|
2004-02-17 |
2005-08-18 |
Bruinsma Gosse B. |
Combinatorial therapy with an acetylcholinesterase inhibitor and (3aR)-1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydropyrrolo[2,3,-b]indol-5-yl phenylcarbamate
|
|
UA85699C2
(en)
|
2004-02-25 |
2009-02-25 |
Эли Лилли Энд Компани |
6-substituted 2,3,4,5-tetrahydro-1h-benzo[d]azepines as 5-ht2c receptor agonists
|
|
WO2005092009A2
(en)
|
2004-03-19 |
2005-10-06 |
Axonyx, Inc. |
Acetylcholinesterase inhibitors and n-methyl-d-aspartate antagonists useful in the treatment of cognitive disorders
|
|
US7618978B2
(en)
|
2004-04-22 |
2009-11-17 |
Eli Lilly And Company |
Amides as BACE inhibitors
|
|
US20070212428A1
(en)
|
2004-06-04 |
2007-09-13 |
Mood Management Sciences, Inc. |
Methods and compositions for treating mood disorder
|
|
WO2005120523A1
(en)
|
2004-06-04 |
2005-12-22 |
Mood Management Sciences, Llc |
Methods and compositions for treating mood disorder
|
|
CA2568700A1
(en)
|
2004-06-11 |
2005-12-22 |
Ucb, S.A. |
Process for preparing 2-oxo-1-pyrrolidine derivatives by intramolecular allylation
|
|
US20060063707A1
(en)
|
2004-09-17 |
2006-03-23 |
Lifelike Biomatic, Inc. |
Compositions for enhancing memory and methods therefor
|
|
US9186345B2
(en)
|
2004-10-12 |
2015-11-17 |
Hakon Hakonarson |
Method of treating skin diseases
|
|
JP2008516949A
(ja)
|
2004-10-18 |
2008-05-22 |
イーライ リリー アンド カンパニー |
選択的エストロゲン受容体βアゴニストとしての置換ベンゾピラン
|
|
WO2006060082A1
(en)
|
2004-10-22 |
2006-06-08 |
THE GOVERNMENT OF THE U.S.A. as represented by THE SEC., DEPT. OF HEALTH & HUMAN SERVICES, NATIONAL INSTITUTES OF HEALTH |
Tricyclic compounds, preparation thereof and use thereof as cholinesterase activity inhibitors
|
|
CN101087618A
(zh)
|
2004-12-23 |
2007-12-12 |
航行药物公司 |
醋酸亮丙瑞林和乙酰胆碱酯酶抑制剂或nmda受体抑制剂在阿尔茨海默氏病治疗中的应用
|
|
WO2006070394A1
(en)
|
2004-12-28 |
2006-07-06 |
Council Of Scientific And Industrial Research |
Substituted carbamic acid quinolin-6-yl esters useful as acetylcholinesterase inhibitors
|
|
NZ556630A
(en)
*
|
2005-01-27 |
2010-12-24 |
Alembic Ltd |
Extended release formulation of levetiracetam including a hydrophilic rate controlling polymer
|
|
FR2881618B1
(fr)
|
2005-02-10 |
2007-04-13 |
Centre Nat Rech Scient |
Utilisation de composes derives de pyrimidinetrione en tant qu'inhibiteurs de l'acetylcholinesterase, compositions contenant ces derives et leurs utilisations en tant qu'insecticides
|
|
US20070298098A1
(en)
|
2005-02-16 |
2007-12-27 |
Elan Pharma International Limited |
Controlled Release Compositions Comprising Levetiracetam
|
|
US8431156B2
(en)
*
|
2005-02-22 |
2013-04-30 |
Sun Pharma Advanced Research Company Ltd. |
Pharmaceutical composition
|
|
AU2006228947A1
(en)
|
2005-03-30 |
2006-10-05 |
Mylan Pharmaceuticals Ulc |
Combined-step process for pharmaceutical compositions
|
|
BRPI0607017B8
(pt)
|
2005-04-06 |
2021-05-25 |
Adamas Pharmaceuticals Inc |
composição farmacêutica compreendendo memantina e donezepil, e seu uso para o tratamento de condições relacionadas ao snc
|
|
US20060241144A1
(en)
|
2005-04-20 |
2006-10-26 |
Albert Cha |
Method for treating apathy syndrome
|
|
EP1890700A2
(en)
|
2005-05-31 |
2008-02-27 |
Orexigen Therapeutics, Inc. |
Methods and compositions for managing psychotic disorders
|
|
EP1731149A1
(en)
|
2005-06-08 |
2006-12-13 |
Ucb S.A. |
Use of 2-oxo-1-pyrrolidone derivatives for the treatment of diseases characterized by progressive myoclonic epilepsy
|
|
SI1909764T1
(sl)
*
|
2005-07-26 |
2015-01-30 |
Ucb Pharma, S.A. |
Farmacevtski sestavki, ki obsegajo levetiracetam in postopek za njihovo pripravo
|
|
EP2682481A3
(en)
|
2005-08-03 |
2014-09-17 |
The Johns-Hopkins University |
Methods for characterizing and treating cognitive impairment in aging and disease
|
|
GB0517740D0
(en)
|
2005-08-31 |
2005-10-12 |
Novartis Ag |
Organic compounds
|
|
US20100216734A1
(en)
|
2006-03-08 |
2010-08-26 |
Braincells, Inc. |
Modulation of neurogenesis by nootropic agents
|
|
EP1991212A1
(en)
|
2006-03-08 |
2008-11-19 |
Braincells, Inc. |
Modulation of neurogenesis by nootropic agents
|
|
JP2009531323A
(ja)
|
2006-03-20 |
2009-09-03 |
カウンシル オブ サイエンティフィック アンド インダストリアル リサーチ |
アセチルコリンエステラーゼ阻害剤として有用な薬剤組成物
|
|
CA2650711A1
(en)
|
2006-04-28 |
2007-11-08 |
Northwestern University |
Compositions and treatments using pyridazine compounds and cholinesterase inhibitors
|
|
US7858611B2
(en)
|
2006-05-09 |
2010-12-28 |
Braincells Inc. |
Neurogenesis by modulating angiotensin
|
|
CA2651862A1
(en)
|
2006-05-09 |
2007-11-22 |
Braincells, Inc. |
5 ht receptor mediated neurogenesis
|
|
US8572930B2
(en)
|
2006-06-05 |
2013-11-05 |
Worthington Armstrong Venture |
Single layered web beam for a drywall suspended ceiling
|
|
CN101506157B
(zh)
|
2006-06-08 |
2013-07-24 |
Ucb医药有限公司 |
吡咯烷酮共结晶
|
|
US20080014271A1
(en)
|
2006-07-13 |
2008-01-17 |
Ucb, S.A. |
Novel pharmaceutical compositions comprising levetiracetam
|
|
WO2008021666A2
(en)
|
2006-08-18 |
2008-02-21 |
Morton Grove Pharmaceuticals, Inc. |
Stable liquid levetiracetam compositions and methods
|
|
WO2008062446A2
(en)
*
|
2006-09-14 |
2008-05-29 |
Alembic Limited |
An extended release composition of levetiracetam, which exhibits no adverse food effect
|
|
AU2007299726A1
(en)
|
2006-09-22 |
2008-03-27 |
Braincells, Inc. |
Combination comprising an HMG-COA reductase inhibitor and a second neurogenic agent for treating a nervous system disorder and increasing neurogenesis
|
|
CA2667553A1
(en)
|
2006-10-27 |
2008-05-02 |
Medivation Neurology, Inc. |
Methods and combination therapies for treating alzheimer's disease
|
|
WO2008073452A1
(en)
|
2006-12-11 |
2008-06-19 |
Reviva Pharmaceuticals, Inc. |
Compositions, synthesis, and methods of using indanone based cholinesterase inhibitors
|
|
WO2008074896A1
(en)
|
2006-12-21 |
2008-06-26 |
Prendergast Patrick T |
Compositions and methods for treatment of chronic neurological disorders
|
|
EP2125709A2
(en)
|
2007-02-02 |
2009-12-02 |
Colucid Pharmaceuticals, Inc. |
Compounds that inhibit cholinesterase
|
|
FR2912056B1
(fr)
|
2007-02-05 |
2009-12-18 |
Rd Pharmagal |
Composition a liberation prolongee de levetiracetam et procede de preparation
|
|
WO2008095221A1
(en)
|
2007-02-07 |
2008-08-14 |
Gosforth Centre (Holdings) Pty Ltd |
Treatment of adhd
|
|
US7846930B2
(en)
|
2007-05-18 |
2010-12-07 |
Janssen Pharmaceutica Nv |
Diaryl-substituted tetrahydroisoquinolines as histamine H3 receptor and serotonin transporter modulators
|
|
RU2339620C1
(ru)
|
2007-07-09 |
2008-11-27 |
Общество С Ограниченной Ответственностью "Фармвинг" |
Оксалат n, n-диметил-2-n, n-диметиламинометилпиридил-3-карбамат, обладающий антихолинэстеразной активностью и способностью улучшать когнитивные функции
|
|
JP2010533126A
(ja)
|
2007-07-13 |
2010-10-21 |
エーザイ・アール・アンド・ディー・マネジメント株式会社 |
神経因性疼痛の治療ためのａｍｐａ受容体アンタゴニストとアセチルコリンエステラーゼ阻害剤との併用
|
|
US20090030403A1
(en)
*
|
2007-07-27 |
2009-01-29 |
Leyde Kent W |
Methods and Systems for Attenuating the Tolerance Response to a Drug
|
|
KR20090031333A
(ko)
|
2007-09-21 |
2009-03-25 |
주식회사 엘지생명과학 |
신규한 베타-세크리타제 저해용 화합물
|
|
US20090176740A1
(en)
|
2007-11-30 |
2009-07-09 |
Phillips Ii Dauglas James |
Treatment of neurological conditions by the co-administration of aniracetam and l-alpha glycerylphosphorylcholine
|
|
EP2254577A1
(en)
|
2007-12-26 |
2010-12-01 |
Eisai R&D Management Co., Ltd. |
Ampa receptor antagonists for epilepsy, mental disorders or deficits in sensory organ
|
|
PT2273975E
(pt)
|
2008-03-03 |
2014-07-17 |
Ucb Pharma Sa |
Processos de preparação e utilizações terapêuticas de soluções farmacêuticas
|
|
JP2010024156A
(ja)
|
2008-07-16 |
2010-02-04 |
Ucb Pharma Sa |
レベチラセタムを含む医薬組成物
|
|
MX2011001384A
(es)
|
2008-08-06 |
2011-09-27 |
Gosforth Ct Holdings Pty Ltd |
Composiciones y metodos para tratar trastornos psiquiatricos.
|
|
ES2865504T3
(es)
|
2008-10-16 |
2021-10-15 |
Univ Johns Hopkins |
Procedimientos y composiciones para la mejora de la función cognitiva
|
|
US9125898B2
(en)
|
2008-11-14 |
2015-09-08 |
Neurotune Ag |
Acetam derivatives for pain relief
|
|
WO2010057088A2
(en)
|
2008-11-17 |
2010-05-20 |
Auspex Pharmaceuticals, Inc. |
Pyrrolidinyl modulators of nicotinic acetylcholine receptors
|
|
PL2358360T3
(pl)
|
2008-11-18 |
2017-02-28 |
Ucb Biopharma Sprl |
Preparaty o przedłużonym uwalnianiu zawierające pochodną 2-okso-1-pirolidyny
|
|
US20100172979A1
(en)
|
2008-12-24 |
2010-07-08 |
Zhongshui Yu |
Controlled-release formulations
|
|
US20110275693A1
(en)
|
2009-01-29 |
2011-11-10 |
Ucb Pharma, S.A. |
Pharmaceutical Compositions Comprising 2-Oxo-1-Pyrrolidine Derivatives
|
|
WO2010089372A1
(en)
|
2009-02-09 |
2010-08-12 |
Ucb Pharma, S.A. |
Pharmaceutical compositions comprising brivaracetam
|
|
EP2405913A1
(en)
|
2009-03-09 |
2012-01-18 |
Bristol-Myers Squibb Company |
Pyridone analogs useful as melanin concentrating hormone receptor-1 antagonists
|
|
EP2461808A2
(en)
|
2009-08-07 |
2012-06-13 |
UCB Pharma S.A. |
Methods for enhancing the cognitive function
|
|
CN101647789B
(zh)
|
2009-09-01 |
2011-08-17 |
天津药物研究院药业有限责任公司 |
左乙拉西坦缓释微丸胶囊制剂
|
|
CN102548544B
(zh)
|
2009-10-09 |
2015-01-21 |
永进药品工业株式会社 |
同时具有速效特性和长效特性的药物组合物
|
|
US20110262442A1
(en)
|
2009-11-06 |
2011-10-27 |
Adenios, Inc. |
Compositions for treating cns disorders
|
|
EA037187B1
(ru)
|
2010-02-09 |
2021-02-17 |
Дзе Джонс Хопкинс Юниверсити |
Способ и композиция для лечения когнитивного расстройства
|
|
WO2011143721A1
(en)
|
2010-05-21 |
2011-11-24 |
Gosforth Centre (Holdings) Pty Ltd |
Compositions and methods for treating neurodegenerative disorders
|
|
KR20120055313A
(ko)
|
2010-11-23 |
2012-05-31 |
주식회사 바이오파마티스 |
레베티라세탐 또는 이의 약학적으로 허용되는 염을 포함하는 용출 안정성이 개선된 서방형 약학 조성물 및 이의 제조방법
|
|
AU2011336217B2
(en)
|
2010-12-01 |
2015-10-01 |
Pfizer Inc. |
KAT II inhibitors
|
|
BR112013020283A2
(pt)
*
|
2011-02-09 |
2016-07-19 |
Univ Johns Hopkins |
"uso de inibidor de proteína de vesícula sináptica 2a (sv2a), valproato, levetiracetam, brivarecetam e seletracetam no tratamento de deficiência cognitiva, bem como composição farmacêutica compreendendo os mesmos"
|
|
DE102011103270A1
(de)
*
|
2011-05-26 |
2012-11-29 |
Stada Arzneimittel Ag |
Pulverförmige Mischung zur Herstellung von Levetiracetam-haltigen Tabletten
|
|
GB201111712D0
(en)
|
2011-07-08 |
2011-08-24 |
Gosforth Ct Holdings Pty Ltd |
Pharmaceutical compositions
|
|
CA2877134A1
(en)
|
2012-08-08 |
2014-02-13 |
PharmTak, Inc. |
Extended-release levetiracetam and method of preparation
|
|
US10154988B2
(en)
|
2012-11-14 |
2018-12-18 |
The Johns Hopkins University |
Methods and compositions for treating schizophrenia
|
|
WO2014144546A1
(en)
|
2013-03-15 |
2014-09-18 |
The Johns Hopkins University |
Methods and compositons for improving cognitive function
|
|
US10806717B2
(en)
|
2013-03-15 |
2020-10-20 |
The Johns Hopkins University |
Methods and compositions for improving cognitive function
|
|
JP6433482B2
(ja)
|
2013-03-15 |
2018-12-05 |
エージンバイオ， インコーポレイテッド |
認知機能を改善するための方法および組成物
|
|
CN104586806B
(zh)
*
|
2014-12-26 |
2018-03-13 |
东北制药集团沈阳第一制药有限公司 |
一种左乙拉西坦缓释片及其制备方法
|
|
AU2016268096B2
(en)
|
2015-05-22 |
2021-04-01 |
Agenebio, Inc. |
Extended release pharmaceutical compositions of levetiracetam
|